Lupin Expands Europe Access to YUVEZZI Presbyopia Therapy
Mumbai, India; Amsterdam, Netherlands; London, UK; Naples, Florida; Warren, New Jersey, August 20, 2026 Lupin Limited and Tenpoint Therapeutics...
AI governance
Advertisement
HealthTab and Abbott Expand UK Point-of-Care Testing
Vancouver, British Columbia, August 20, 2026 Avricore Health Inc. has announced that its wholly owned subsidiary, HealthTab Ltd., has...
FDA Seeks Input on Generative AI Medical Device Rules
Silver Spring, Maryland, August 18, 2026 The U.S. Food and Drug Administration (FDA) has issued a new discussion paper...
Antengene Advances Key R&D Programs in Biotech Pipeline
SHANGHAI and HONG KONG, August 18, 2026 Antengene Corporation Limited, a commercial-stage global biotechnology company focused on innovative therapies...
Enlil Launches Governed AI for MedTech Regulation
CAMPBELL, Calif., August 18, 2026 Enlil, Inc. has introduced a four-layer governed AI architecture designed to help medical device...
Advertisements
Remepy Reports Strong Hybridopa Parkinson’s Trial Data
NEW YORK, N.Y., May 20, 2026 Remepy has announced positive results from its Phase IIa clinical trial evaluating Hybridopa™,...
Optimi Health Prices $15M Nasdaq Uplisting Offering
VANCOUVER, British Columbia, May 20, 2026 Optimi Health Corp. has announced the pricing of an oversubscribed US$15 million underwritten...
Paragon Institute Proposes Safer Future for AI Medical Devices
BOSTON, Mass., May 20, 2026 The Paragon Institute has released a new scientific proposal highlighting the growing risks associated...
Advertisement
